Home    Back

Glyceryl triacetate    (DrugBank: Glyceryl triacetate)

1 disease
IDDisease name (Link within this page)Number of trials
307Canavan disease2

307. Canavan disease    [ 3 clinical trials,   5 drugs,   (DrugBank: 1 drug),   0 drug target gene,   0 drug target pathway]
Searched query = "Canavan disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 3 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00657748
(ClinicalTrials.gov)		September 20099/4/2008Lithium and Acetate for Canavan DiseaseEvaluation of the Tolerance and Efficiency of a Combined Oral Therapy With Lithium and GTA in Patients With Canavan DiseaseCanavan Disease;Infantile;Deficiency Disease;Aspartoacylase;Leukodystrophy, SpongiformDrug: Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)Assistance Publique - Hôpitaux de ParisEuropean Leukodystrophy Association;European Leukodystrophy AssociationWithdrawn1 Year15 YearsBoth0Phase 2France
2NCT00724802
(ClinicalTrials.gov)		March 200818/6/2008Oral Glyceryl Triacetate (GTA) in Newborns With CanavanOral Glyceryl Triacetate (GTA) in Newborns With CanavanCanavan DiseaseDietary Supplement: GTA (Glyceryl triacetate);Drug: GTA glyceryl triacetateShaare Zedek Medical CenterNULLRecruitingN/A18 MonthsBoth1N/AIsrael